Jeffrey S. Flier Sells 11,136 Shares of Scholar Rock Holding Corporation (NASDAQ:SRRK) Stock

Scholar Rock Holding Corporation (NASDAQ:SRRK) Director Jeffrey S. Flier sold 11,136 shares of the stock in a transaction that occurred on Monday, June 23rd. The stock was sold at an average price of $33.21, for a total value of $369,826.56. Following the sale, the director now directly owns 11,136 shares of the company’s stock, valued at approximately $369,826.56. The trade was a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Scholar Rock Stock Performance

NASDAQ SRRK opened at $35.81 on Thursday. The firm has a market capitalization of $3.40 billion, a P/E ratio of -14.15 and a beta of 0.28. The company has a current ratio of 10.25, a quick ratio of 10.25 and a debt-to-equity ratio of 0.16. The firm’s fifty day moving average price is $31.92 and its two-hundred day moving average price is $35.88. Scholar Rock Holding Corporation has a 1 year low of $6.76 and a 1 year high of $46.98.

Scholar Rock (NASDAQ:SRRK) last issued its earnings results on Wednesday, May 14th. The company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.63) by ($0.04). During the same quarter in the prior year, the company earned ($0.59) EPS. As a group, research analysts anticipate that Scholar Rock Holding Corporation will post -2.42 EPS for the current year.

Institutional Trading of Scholar Rock

Several institutional investors and hedge funds have recently bought and sold shares of SRRK. CWM LLC increased its holdings in shares of Scholar Rock by 152.8% during the 1st quarter. CWM LLC now owns 996 shares of the company’s stock worth $32,000 after acquiring an additional 602 shares during the last quarter. Global Retirement Partners LLC boosted its position in Scholar Rock by 584.7% during the fourth quarter. Global Retirement Partners LLC now owns 897 shares of the company’s stock worth $39,000 after purchasing an additional 766 shares during the period. Federated Hermes Inc. acquired a new position in shares of Scholar Rock in the first quarter valued at $71,000. GF Fund Management CO. LTD. boosted its holdings in shares of Scholar Rock by 21.9% during the 1st quarter. GF Fund Management CO. LTD. now owns 2,396 shares of the company’s stock worth $77,000 after buying an additional 430 shares during the period. Finally, Strs Ohio bought a new stake in shares of Scholar Rock during the 1st quarter worth about $77,000. Institutional investors own 91.08% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Wedbush reaffirmed an “outperform” rating and issued a $50.00 price target on shares of Scholar Rock in a research note on Wednesday, June 18th. Lifesci Capital raised shares of Scholar Rock to a “strong-buy” rating in a research report on Tuesday, June 3rd. Six equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Scholar Rock currently has an average rating of “Buy” and an average price target of $42.67.

Scholar Rock Company Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies.